Cellectis SA (CLLS)
3.43
-0.12
(-3.52%)
USD |
NASDAQ |
Aug 28, 16:00
3.43
0.00 (0.00%)
After-Hours: 20:00
Cellectis Free Cash Flow : -45.36M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.36M |
| March 31, 2026 | -41.80M |
| December 31, 2025 | -43.68M |
| September 30, 2025 | -34.73M |
| June 30, 2025 | -37.66M |
| March 31, 2025 | 24.39M |
| December 31, 2024 | 18.30M |
| September 30, 2024 | 59.64M |
| June 30, 2024 | 49.08M |
| March 31, 2024 | -21.41M |
| December 31, 2023 | -26.23M |
| September 30, 2023 | -67.39M |
| June 30, 2023 | -76.45M |
| March 31, 2023 | -81.40M |
| December 31, 2022 | -90.02M |
| September 30, 2022 | -110.08M |
| June 30, 2022 | -119.60M |
| March 31, 2022 | -112.75M |
| December 31, 2021 | -124.66M |
| September 30, 2021 | -154.66M |
| Date | Value |
|---|---|
| June 30, 2021 | -150.54M |
| March 31, 2021 | -169.17M |
| December 31, 2020 | -126.52M |
| September 30, 2020 | -80.18M |
| June 30, 2020 | -76.34M |
| March 31, 2020 | -64.38M |
| December 31, 2019 | -82.10M |
| September 30, 2019 | -99.47M |
| June 30, 2019 | -87.60M |
| March 31, 2019 | -76.45M |
| December 31, 2018 | -72.85M |
| September 30, 2018 | -59.94M |
| June 30, 2018 | -60.00M |
| March 31, 2018 | -57.67M |
| December 31, 2017 | -54.98M |
| September 30, 2017 | -39.10M |
| June 30, 2017 | -32.39M |
| March 31, 2017 | -35.46M |
| December 31, 2016 | -46.73M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -152.18M |
| Akari Therapeutics Plc | -10.74M |
| EDAP TMS SA | -- |
| Autolus Therapeutics Plc | -240.12M |
| Evaxion AS | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.34M |
| Cash from Investing (Quarterly) | 18.75M |
| Cash from Financing (Quarterly) | -3.157M |
| Free Cash Flow Per Share (Quarterly) | -0.145 |
| Free Cash Flow to Equity (Quarterly) | -10.27M |
| Free Cash Flow to Firm (Quarterly) | -12.72M |
| Free Cash Flow Yield | -13.12% |